Imaging scan to find neuroendocrine tumors in adults
Tests a PET scan that detects somatostatin-positive neuroendocrine tumors in adults.
Plain-language title generated from the registry record
Registry title: 68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
Key facts
- Where
- Calgary, CanadaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Source: NCT05673031, who can take part
Where in Canada
- Foothills Medical Center 1403 29 St NWCalgary, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Alberta Health services
- Trial code
- NCT05673031
- Record updated
- 5 January 2023
- Original description
To determine if 68Ga-HA-DOTATATE PET/CT imaging is effective at diagnosing somatostatin positive tumors compared to conventional imaging [including CT, MRI, 111 In-pentetreotide Scans, 18F-FDG PET/CT, as available]Read full original descriptionShow less
68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
To determine if 68Ga-HA-DOTATATE PET/CT imaging is effective at diagnosing somatostatin positive tumors compared to conventional imaging [including CT, MRI, 111 In-pentetreotide Scans, 18F-FDG PET/CT, as available]
Inclusion: Male or female. If female of child-bearing potential and outside of the window of 10 days since the last menstrual period, a negative pregnancy test will be required; Age greater than or equal to 18 years; Able and willing to follow instructions and comply with the protocol; Provide written informed consent prior to participation in the study; Clinically suspected (patients presenting with symptom(s) suggestive of carcinoid syndrome or biochemically suggestive of Neuroendocrine Tumor) or Biopsy proven Neuroendocrine Tumor.
Exclusion: Surgery in the area of interest within the preceding 2 months; Age less than 18 years; Nursing or pregnant females.